Galderma Raises Full-Year Sales Guidance for Second Time in Two Quarters
Galderma raised its full-year sales guidance after robust sales growth in the first nine months, particularly in its therapeutic dermatology division.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Galderma raised its full-year sales guidance after robust sales growth in the first nine months, particularly in its therapeutic dermatology division.